Expanded use case analysis for rapid antigen diagnostics for SARS-CoV-2 mitigation. Phase 2 results from the ACT-Accelerator SARS-CoV-2 rapid antigen testing modelling consortium.
Category: Resource Centre – Publications
Expanded use case analysis for Phase 1 Results from the ACT-Accelerator SARS-COV-2 Rapid Antigen testing Modelling Consortium Rapid antigen diagnostics for SARS-CoV-2 mitigation.
When COVID-19 emerged in early 2020, the Global Fund took swift action to fight the pandemic and protect hard-won gains against HIV, tuberculosis (TB) and malaria. With the support of our generous donors, we have since awarded more than US$4.4 billion to help countries respond to the new virus, mitigate its impact on lifesaving HIV, TB and malaria services and make urgent improvements to health systems. While we were not able to prevent COVID-19 from having a massive impact on people living in low- and middle-income countries, including both the direct impact of the new virus and the reversal of hard-won gains against HIV, TB and malaria, it could have been much worse.
We saw the benefits of the interventions we made in 2021, with gains in key programmatic results across all three diseases. The Global Fund’s Results Report 2022 details how our partnership played a critical role in supporting countries and communities to respond to the pandemic and continue the progress in the fight against HIV, TB and malaria.
This page contains the documents published in May 2021 when the Panel’s main report, entitled COVID-19: Make it the Last Pandemic, was released. These include the main report, a summary, an evidence-based narrative report, background documents, a report reflecting voices heard in townhall meetings, and multimedia materials including videos. Also included on this page is a sample of global public reaction following the report’s release.
The impact of COVID-19 on HIV, TB and Malaria Services and Systems for Health: A snapshot from 502 health facilities across Africa and Asia.
Regional Roundtable meeting on
‘Access to COVID-19 Tools-Accelerator (ACT-A)
diagnostics pillar’ in the
WHO South-East Asia Region
New Delhi, India, 24 August 2021
COVID-19 Diagnostics are tests used to detect infection with the SARS-COV-2 virus.
Download Information Sheet: English
Download Information Sheet: French
Diagnostics are an essential part of a well functioning and high-quality health system. Yet, almost half of the global population has little or no access to diagnostics. The COVID-19 pandemic has shown acutely that diagnostic capacity in a country is directly linked to the ability to respond to the pandemic with appropriate public health measures and to monitor emerging variants. There is an urgent need to strengthen diagnostics for future pandemic preparedness but also beyond pandemics. Diagnostics are central to an accurate diagnosis of communicable and non-communicable diseases, to guide therapy, monitor progress, and assess response to treatment. The Commission puts forward recommendations to accelerate and transform access to diagnostics globally.